From 1990 to 2016, the share of women in the life sciences industry increased from 34 to 47 percent. Women also make up more than half of Ph.Ds. in biological and agricultural sciences. And many researchers are working to address health issues affecting women, ranging from endometriosis to heart conditions. Industry leaders, policymakers and academics have also shown how they’re dedicated to continuing to support innovation — and this includes fostering the next generation of scientists through STEM education programs.
The panelists will discuss what the new era of medicine means for women’s health, how the biopharmaceutical industry is empowering women and girls, and what they think the future of science will look like.
To RSVP for this event, please visit here.
- Lori Reilly, executive vice president, policy, research and membership, PhRMA
- Dr. Anne Pritchett, senior vice president, policy, research and membership, PhRMA
- Charlotte Jones-Burton, M.D., M.S., executive director, R&D, innovative medicines development, development team lead, cardiovascular, Bristol Myers Squibb
- Dr. Sabine Luik, chief medical officer and senior vice president, Global Medical, Regulatory and Quality, GSK
- Amy M. Miller, Ph.D., president and CEO, the Society for Women’s Health Research
- Jean Beebe, Ph.D., vice president, clinical portfolio leader, inflammation and immunology, Pfizer
- Lana Skirboll, Ph.D., vice president of science policy, Sanofi
Other speakers to be announced.
Wednesday, May 1, 2019
10:00 AM - 11:00 AM EST
Cannon House Office Building
Independence Ave SE
Washington, DC 20003